WO2002040511A3 - Sequence d'adn et microcine de la souche dsm 6601 d'escherichia coli - Google Patents

Sequence d'adn et microcine de la souche dsm 6601 d'escherichia coli

Info

Publication number
WO2002040511A3
WO2002040511A3 PCT/EP2001/012937 EP0112937W WO0240511A3 WO 2002040511 A3 WO2002040511 A3 WO 2002040511A3 EP 0112937 W EP0112937 W EP 0112937W WO 0240511 A3 WO0240511 A3 WO 0240511A3
Authority
WO
WIPO (PCT)
Prior art keywords
dna sequence
microcine
escherichia coli
coli strain
strain dsm
Prior art date
Application number
PCT/EP2001/012937
Other languages
German (de)
English (en)
Other versions
WO2002040511A2 (fr
WO2002040511A9 (fr
Inventor
Joerg Hacker
Gabriele Blum-Oehler
Guenther Jung
Klaus Hantke
Silke Patzer
Felipe Moreno
Fernando Baquero
Rosario Baquero
Daniel Bravo
Ulrich Sonnenborn
Juergen Schulze
Hans Proppert
Original Assignee
Pharma Zentrale Gmbh
Joerg Hacker
Gabriele Blum-Oehler
Guenther Jung
Klaus Hantke
Silke Patzer
Felipe Moreno
Fernando Baquero
Rosario Baquero
Daniel Bravo
Ulrich Sonnenborn
Juergen Schulze
Hans Proppert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Zentrale Gmbh, Joerg Hacker, Gabriele Blum-Oehler, Guenther Jung, Klaus Hantke, Silke Patzer, Felipe Moreno, Fernando Baquero, Rosario Baquero, Daniel Bravo, Ulrich Sonnenborn, Juergen Schulze, Hans Proppert filed Critical Pharma Zentrale Gmbh
Priority to AU2002237220A priority Critical patent/AU2002237220A1/en
Publication of WO2002040511A2 publication Critical patent/WO2002040511A2/fr
Publication of WO2002040511A9 publication Critical patent/WO2002040511A9/fr
Publication of WO2002040511A3 publication Critical patent/WO2002040511A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Mobile Radio Communication Systems (AREA)

Abstract

L'invention concerne une séquence d'ADN présentant la suite de nucléotides représentée à la figure 1, le peptide codé par ladite séquence, des dérivés de ce peptide ainsi que l'utilisation de la séquence d'ADN, du peptide et des dérivés dudit peptide.
PCT/EP2001/012937 2000-11-10 2001-11-08 Sequence d'adn et microcine de la souche dsm 6601 d'escherichia coli WO2002040511A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002237220A AU2002237220A1 (en) 2000-11-10 2001-11-08 Dna sequence and microcine from escherichia coli strain dsm 6601

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10055789A DE10055789A1 (de) 2000-11-10 2000-11-10 DNA-Sequenz und Microcin aus Escherichia coli StammDSM 6601
DE10055789.9 2000-11-10

Publications (3)

Publication Number Publication Date
WO2002040511A2 WO2002040511A2 (fr) 2002-05-23
WO2002040511A9 WO2002040511A9 (fr) 2002-07-25
WO2002040511A3 true WO2002040511A3 (fr) 2002-12-05

Family

ID=7662846

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/012937 WO2002040511A2 (fr) 2000-11-10 2001-11-08 Sequence d'adn et microcine de la souche dsm 6601 d'escherichia coli

Country Status (3)

Country Link
AU (1) AU2002237220A1 (fr)
DE (1) DE10055789A1 (fr)
WO (1) WO2002040511A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2545679A1 (fr) 2003-11-12 2005-05-26 The University Of Georgia Research Foundation, Inc. Transport facilite par la biotine dans des bacteries gram negatif

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
AZPIROZ MARIA F ET AL: "The structure, function, and origin of the microcin H47 ATP-binding cassette exporter indicate its relatedness to that of colicin V.", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 45, no. 3, March 2001 (2001-03-01), pages 969 - 972, XP002207827, ISSN: 0066-4804 *
BLUM ET AL: "Properties of Escherichia coli strains of serotype O6", PLASMID, NEW YORK,NY, US, vol. 23, no. 4, 1 July 1995 (1995-07-01), pages 234 - 236, XP002085750, ISSN: 0147-619X *
DOBRINDT ULRICH ET AL: "S-fimbria-encoding determinant sfaI is located on pathogenicity island III536 of uropathogenic Escherichia coli strain 536.", INFECTION AND IMMUNITY, vol. 69, no. 7, July 2001 (2001-07-01), pages 4248 - 4256, XP002207828, ISSN: 0019-9567 *

Also Published As

Publication number Publication date
WO2002040511A2 (fr) 2002-05-23
AU2002237220A1 (en) 2002-05-27
WO2002040511A9 (fr) 2002-07-25
DE10055789A1 (de) 2002-06-06

Similar Documents

Publication Publication Date Title
AU2001258229A1 (en) Alpha-amylase variants with altered 1,6-activity
WO2003029271A3 (fr) Nouveaux acides nucleiques et polypeptides
AU8146601A (en) AKT nucleic acids, polypeptides, and uses thereof
AU4390099A (en) Nucleotide sequences of the apple lrpkm1 gene, encoded amino acid sequence and uses thereof
AU2001265096A1 (en) Short-root gene, promoter, and uses thereof
WO2002040511A3 (fr) Sequence d'adn et microcine de la souche dsm 6601 d'escherichia coli
WO1998044134A3 (fr) Plasmides bacteriens
WO2002087604A3 (fr) Preparations de vitamine e en combinaison avec l'afamine
WO1997031114A3 (fr) Polynucleotides et sequences d'acides amines provenant de staphylococcus aureus
EP1382680A4 (fr) Beta 1,3-galactose transferase et adn codant pour cette enzyme
AU2001264955A1 (en) Human cyslt2 nucleic acids, polypeptides, and uses thereof
AU2001276210A1 (en) Cloning, sequencing and expression of a comamonas cyclopentanone 1,2-monooxygenase-encoding gene in escherichia coli
AU2002218232A1 (en) L-threonine producing e. coli strain
WO2001064839A3 (fr) Nouveaux acides nucleiques et polypeptides exprimes par des macrophages
AU2001273224A1 (en) Isolated polynucleotides encoding human 5'-nucleotide cn-ia and cn-ib, isolated proteins encoded by the same, and methods utilizing the same
AU2002217863A1 (en) Homing peptide multimers, their preparation and uses
AU2001282259A1 (en) Nucleic acids and pathogenic e.coli proteins, and their uses
WO2001055209A3 (fr) Nouvelle septine humaine et utilisations
WO2002079390A9 (fr) Proteines $i(pesudomonas) avr et hop, acides nucleiques codants ces proteines, et leurs utilisations
WO2002060933A3 (fr) INHIBITION DE L'ACTIVATION NF-λB
AU2002214916A1 (en) A novel polypeptide, a human garp protein 12.98 and the polynucleotide encoding the polypeptide
EP1591448A3 (fr) Nouveaux acides nucleiques et polypeptides
AU2001239742A1 (en) Nucleic acids, encoding human crsp1 and uses thereof
AU2003226712A1 (en) Protein kinase c modulators, their aminoacid and nucleotide sequences and uses thereof
AU2001295405A1 (en) A novel polypeptide, a human dna polymerase delta 12.65 and the polynucleotide encoding the polypeptide

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: DUE TO A SCANNING ERROR DURING THE TECHNICAL PREPARATIONS FOR INTERNATIONAL PUBLICATION, REPLACE ALL PAGES (INCLUDING FRONT PAGE) BY CORRECT PAGES (18 PAGES)

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP